Milestone
Investor Data Room now open
MEDIPASS opens its investor data room with the Seed deck, one-pager and financial model available under light NDA.
Access the data roomInvestor Relations
MEDIPASS is building the universal digital health passport.
A secure, multilingual and interoperable health identity layer designed for patients, healthcare providers, insurers and institutions worldwide.
Request Investor Briefing View Platform Demo
Download one-pager (PDF)
Back to homeGenerated on request, dated, with no financial metrics or projections.
Built for trust, consent, interoperability and cross-border healthcare access.
Investor Thesis
Why investors are looking at digital health infrastructure now.
Fragmented medical identity
Health records remain tied to individual institutions and national systems. There is no portable, patient-controlled identity layer across providers and borders.
Cross-border healthcare growth
Mobility, expatriation, medical travel and remote care create demand for health information that follows the patient, not the institution.
Insurance and care coordination pressure
Insurers and care networks need verified, consent-based access to health context to reduce duplication, delays and administrative friction.
AI-ready health data infrastructure
Clinical AI is limited by data access and consent. Structured, permissioned health identity is a prerequisite layer, not an add-on.
Market Opportunity
A structural market, not a niche application.
MEDIPASS addresses several converging segments of healthcare digitalisation. Detailed sizing and assumptions are shared in the investor briefing rather than published on this page.
Digital health
Ongoing shift of care pathways, records and coordination to digital platforms.
Health identity
Verified identity and credentials as the foundation of digital care access.
Patient-controlled records
Regulatory and consumer momentum toward patient ownership of health data.
Insurance coordination
Claims, prior authorisation and member services requiring reliable health context.
Institutional modernisation
Government and public-private programmes modernising national health infrastructure.
Market sizing available upon request
No market figures are published here. Sizing is provided with sources and methodology on request.
Positioning
Not another medical record. A health passport infrastructure layer.
MEDIPASS is designed to sit above existing systems rather than replace them.
EHR systems
Institution-centric hospital and clinic records. Powerful internally, rarely portable across providers, countries or payers.
Patient apps
Fragmented wellness and tracking tools. Consumer-friendly, but not designed as trusted infrastructure for clinical or institutional workflows.
MEDIPASS
Portable health passport with consent management, emergency access and institutional workflows — designed to interoperate with existing systems.
Strategic Investor Fit
Where MEDIPASS fits in an institutional portfolio.
Relevant for conversations with sovereign wealth funds, private equity platforms, global asset managers and insurance groups.
Sovereign wealth funds
Long-term infrastructure, healthcare modernisation, public-private health systems.
Private equity and growth funds
Scalable SaaS, healthcare operations, international expansion.
Asset managers and macro investors
Exposure to digital health infrastructure and identity-layer transformation.
Insurers and healthcare groups
Care coordination, claims efficiency, emergency access, member trust.
Investor categories describe the profiles we are built to serve. They do not imply any existing commitment, mandate or partnership.
Business Model
Multiple revenue lanes across patients, providers and institutions.
B2C subscriptions
Individual and family plans for portable health identity and premium access.
B2B provider plans
Clinic, hospital and provider-network subscriptions for intake and continuity workflows.
Insurance and employer partnerships
Member and workforce health passport programmes, built for coordination use cases.
Government and institutional licensing
Licensing designed for national and institutional digital health programmes.
Premium emergency and travel features
Emergency access, multilingual summaries and cross-border travel health services.
Pricing and revenue mix are expected to evolve by market, regulatory regime and distribution partner.
Platform Readiness
What exists today.
A factual view of the current state of the platform, without forward-looking claims.
- Secure authentication
- Multilingual platform
- Patient account foundation
- Live demo environment
- Privacy-first architecture
- Designed for consent-based access
- Roadmap toward institutional integrations
- Pilot-ready deployment scope
Use Cases
Designed for real cross-border healthcare situations.
International traveller emergency access
Critical health information available to emergency responders abroad, under patient consent.
Expatriate healthcare continuity
Continuity of care when moving between countries, providers and health systems.
Insurer member health passport
A shared, consented health reference between member, insurer and care network.
Clinic and hospital patient intake
Faster, more reliable intake for new and international patients.
Government-backed digital health identity pilot
Pilot-ready scope for institutional digital health identity programmes.
Investment Narrative
MEDIPASS sits at the intersection of digital identity, healthcare infrastructure, insurance coordination and AI-ready medical access.
Infrastructure potential
Designed as a layer other systems connect to, not a single-market application.
Global relevance
Multilingual by design and built to support cross-border healthcare access.
Trust-based data layer
Consent, security and auditability as product foundations rather than compliance add-ons.
Next Step
Discuss the next phase of MEDIPASS.
For institutional investors, strategic partners and healthcare groups interested in digital health infrastructure.
Request Investor Briefing Contact FounderView Demo
Download one-pager (PDF)
Generated on request, dated, with no financial metrics or projections.
Investor Relations
Request the investor briefing.
Share your profile and we will follow up with the briefing materials and, where relevant, a founder call.
Investor FAQ
Common questions from institutional investors.
News & Updates
Latest from MEDIPASS.
Announcements, product milestones and investor updates.
Funding
Seed round officially launched
MEDIPASS launches a €1.5M–€2M Seed round to accelerate product development, provider onboarding and international expansion.
Partnership
Pilot discussions across MENA
Active discussions initiated with hospital groups and insurers in the UAE and North Africa around cross-border patient continuity.